Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Indian J Ophthalmol ; 69(6): 1575-1578, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-34011744

RESUMEN

Purpose: The aim of this study was to know proportion of white cataracts from among patients coming for cataract surgery, and to find causes delaying uptake of cataract surgery. Methods: A hospital-based, prospective study enrolled patients of senile cataract between April 2018 and March 2019. The proportion of white cataract was calculated and underlying causes delaying uptake of cataract surgery studied. Results: White cataracts constituted 13.5% of total 3634 senile cataract patients, with gender disparity disfavoring women. Bilateral white cataract was presentation in 39 (8%) patients and lens-related glaucoma in 24 (5%) patients. Pseudophakia in the other eye was single most common cause of delay. Conclusion: A large proportion of white cataracts suggest that penetration of cataract surgical services in not reaching to the most eligible individual.


Asunto(s)
Extracción de Catarata , Catarata , Catarata/diagnóstico , Catarata/epidemiología , Femenino , Humanos , Implantación de Lentes Intraoculares , Estudios Prospectivos , Seudofaquia
2.
Int J Gynaecol Obstet ; 112(1): 34-9, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21112054

RESUMEN

OBJECTIVE: To compare the efficacy of manual vacuum aspiration (MVA) with electric vacuum aspiration (EVA) and to evaluate whether cervical priming with misoprostol facilitates cervical dilation and reduces complications associated with first-trimester medical abortion performed up to 10 weeks of pregnancy. METHODS: A total of 600 women who requested termination of pregnancy were randomized into 4 groups (150 women in each group). Group I and II received a vaginal placebo 3 hours before MVA or EVA, respectively. Group III and IV received 400 µg of vaginal misoprostol 3 hours before MVA or EVA, respectively. RESULTS: Complete abortion rates after MVA and EVA were both 97.9%; after cervical priming with misoprostol complete abortion rates were 98.6% versus 97.3% after cervical priming with placebo (P>0.05). Administration of misoprostol into the vagina before MVA resulted in 99.3% complete abortions (P=0.40), and the least operative blood loss, operating time, and need for cervical dilation (P<0.05). Overall complications and adverse effects were similar in all groups (P>0.05). CONCLUSION: For surgical evacuation, EVA and MVA did not differ in efficacy. Cervical priming 3 hours before MVA for termination of pregnancy significantly reduced the need for cervical dilation and the operative time, and improved the efficacy of the procedure. Pretreatment with vaginal misoprostol before MVA is a safe and effective method for terminating pregnancies of up to 10 weeks of gestation. CLINICAL TRIALS REGISTRY: CTRI/2009/091/000008.


Asunto(s)
Abortivos no Esteroideos/uso terapéutico , Aborto Inducido/métodos , Misoprostol/uso terapéutico , Legrado por Aspiración/métodos , Abortivos no Esteroideos/administración & dosificación , Abortivos no Esteroideos/efectos adversos , Adulto , Pérdida de Sangre Quirúrgica , Maduración Cervical/efectos de los fármacos , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Misoprostol/administración & dosificación , Misoprostol/efectos adversos , Complicaciones Posoperatorias , Embarazo , Primer Trimestre del Embarazo , Estudios Prospectivos , Factores de Tiempo , Legrado por Aspiración/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...